SCHEMBL411184

SCHEMBL411184

CCCCC(CC)CN(CC(CC)CCCC)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.49
KDM4E B2RXH2 1/20 0.49
CYP3A4 P08684 3/20 0.43
CA2 P00918 1/20 0.43
TSHR P16473 3/20 0.42
TDP1 Q9NUW8 1/20 0.39
MEN1 O00255 2/20 0.39
MAPT P10636 2/20 0.39
KMT2A Q03164 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
LMNA P02545 3/20 0.39
HDAC3 O15379 4/20 0.39
HDAC1 Q13547 4/20 0.39
HDAC2 Q92769 4/20 0.39
HDAC8 Q9BY41 4/20 0.39
HDAC6 Q9UBN7 4/20 0.39
HDAC4 P56524 3/20 0.39
HDAC7 Q8WUI4 3/20 0.39
HDAC10 Q969S8 3/20 0.39
HDAC11 Q96DB2 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11413011 0.98 ALDH1A1 (0.48) ALDH1A1KDM4ECYP3A4CA2TSHR
SCHEMBL8438717 0.93 ALDH1A1 (0.47) ALDH1A1KDM4ECYP3A4CA2TSHR
SCHEMBL15009700 0.92 ALDH1A1 (0.43) ALDH1A1KDM4ECYP3A4CA2TSHR
SCHEMBL8440732 0.92 ALDH1A1 (0.46) ALDH1A1KDM4ECYP3A4CA2TSHR
SCHEMBL8438809 0.92 ALDH1A1 (0.46) ALDH1A1KDM4ECYP3A4CA2TSHR
SCHEMBL11904607 0.89 ALDH1A1 (0.43) ALDH1A1KDM4ECYP3A4CA2TSHR
SCHEMBL8435861 0.86 KCNH2 (0.45) ALDH1A1KDM4ETSHR
SCHEMBL411231 0.86 ALDH1A1 (0.49) ALDH1A1KDM4ECYP3A4CA2TSHR
SCHEMBL11329199 0.84 ALDH1A1 (0.41) ALDH1A1KDM4ECYP3A4CA2TSHR
SCHEMBL11722797 0.84 ALDH1A1 (0.48) ALDH1A1KDM4ECYP3A4CA2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9371347-B2 dppf-like compounds and method of manufacture and use BROWN UNIVERSITY (US) 2016-06-21 US claimed
US-20160002274-A1 dppf-LIKE COMPOUNDS AND METHOD FO MANUFACTURE AND USE NATIONAL SCIENCE FOUNDATION 2016-01-07 US claimed
WO-2014130410-A1 DPPF-LIKE COMPOUNDS AND METHODS BROWN UNIVERSITY (US) 2014-08-28 WO claimed
US-4254092-A Method for separating hydrogen chloride and hydrogen bromide CHEMISCHE WERKE HULS AG (DE) 1981-03-03 US claimed
US-20240158424-A1 METHOD FOR PRODUCING DIPHOSPHINE MONOXIDE TAKASAGO INTERNATIONAL CORPORATION (JP) 2024-05-16 US disclosed
EP-4361162-A2 METHOD FOR PRODUCING DIPHOSPHINE MONOXIDE Takasago International Corporation (JP) 2024-05-01 EP disclosed
WO-2023135609-A1 THERMALLY ACTIVATED DELAYED FLUORESCENT SOLVENT-FREE ORGANIC LIQUID COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2023-07-20 WO disclosed
US-20190221375-A1 PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, AND OXIDE SEMICONDUCTOR ELECTRODE FUJIFILM CORPORATION (JP) 2019-07-18 US disclosed
US-9708498-B2 Azo compound, ink containing azo compound, display including said ink and electronic paper MITSUBISHI CHEMICAL CORPORATION (JP) 2017-07-18 US disclosed
US-9708498-B2 Azo compound, ink containing azo compound, display including said ink and electronic paper MITSUBISHI CHEMICAL CORPORATION (JP) 2017-07-18 US disclosed
US-9428438-B2 Process for preparing formic acid BASF SE (DE) 2016-08-30 US disclosed
US-9371347-B2 dppf-like compounds and method of manufacture and use BROWN UNIVERSITY (US) 2016-06-21 US disclosed
EP-0003472-B1 PROCESS FOR SEPARATING HYDROGEN CHLORIDE FROM SOLUTIONS OF AMINO-HYDROCHLORIDES CHEMISCHE WERKE HÜLS AG (DE) 1981-09-16 EP disclosed
EP-0008330-B1 PROCESS FOR THE SEPARATION OF HYDROGEN CHLORIDE AND HYDROGEN BROMINE CHEMISCHE WERKE HÜLS AG (DE) 1981-05-20 EP disclosed
EP-0027623-A1 Composition for the control of suckling mastitis and pyogenes mastitis in cattle Henkel Kommanditgesellschaft auf Aktien (DE) 1981-04-29 EP disclosed
EP-0027508-A1 Process for preparing ammonia and hydrogen chloride from ammonium chloride CHEMISCHE WERKE HÜLS AG (DE) 1981-04-29 EP disclosed
US-4254092-A Method for separating hydrogen chloride and hydrogen bromide CHEMISCHE WERKE HULS AG (DE) 1981-03-03 US disclosed
EP-0008330-A1 Process for the separation of hydrogen chloride and hydrogen bromine CHEMISCHE WERKE HÜLS AG (DE) 1980-03-05 EP disclosed
EP-0003472-A2 Process for separating hydrogen chloride from solutions of amino-hydrochlorides CHEMISCHE WERKE HÜLS AG (DE) 1979-08-22 EP disclosed
US-4115530-A EXTRACTION WITH AMINES CHEMISCHE WERKE HULS AG (DE) 1978-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240158424-A1 METHOD FOR PRODUCING DIPHOSPHINE MONOXIDE TDO2, SCO2, DUOX1 ALDH1A1 1123/4885KDM4E 2631/4885CYP3A4 611/4885
US-20160002274-A1 dppf-LIKE COMPOUNDS AND METHOD FO MANUFACTURE AND USE DBF4, CD22, CD2BP2 ALDH1A1 469/4885KDM4E 3277/4885CYP3A4 437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.